医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
TARS · Tarsus Pharmaceuticals, Inc.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Tarsus Pharmaceuticals, Inc.（TARS）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $5.2M；高管董事有效买入 —、有效卖出 —。最近申报 2026-09-17。
买入 Bought—
卖出 Sold$5.2M
有效买入 Effective bought—
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-09-15 | LINK WILLIAM J PHD Director | 卖出 Sell | 12,500 | $78.38 | $980K | SEC |
| 2026-09-04 | Azamian Bobak R. Director, President/CEO and Board Chair | 卖出 Sell | 10,000 | $90.56 | $906K | SEC |
| 2026-09-04 | Lin Elizabeth Yeu Chief Medical Officer | 卖出 Sell | 13,953 | $87.50 | $1.2M | SEC |
| 2026-09-04 | Neervannan Seshadri Chief Operating Officer | 卖出 Sell | 4,564 | $85.00 | $388K | SEC |
| 2026-09-02 | Azamian Bobak R. Director, President/CEO and Board Chair | 卖出 Sell | 10,000 | $80.06 | $801K | SEC |
| 2026-09-01 | Lin Elizabeth Yeu Chief Medical Officer | 卖出 Sell | 11,578 | $77.56 | $898K | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-09-15 | LINK WILLIAM J PHD DIRECTOR | 12,500 | $980K | 10b5-1 |
| 2026-09-04 | Lin Elizabeth Yeu Officer | 10,773 | $943K | 10b5-1 |
| 2026-09-04 | Azamian Bobak R. OFFICER | 10,000 | $906K | 10b5-1 |
| 2026-09-04 | Neervannan Seshadri Officer | 4,564 | $388K | 10b5-1 |
| 2026-09-04 | Lin Elizabeth Yeu Member of immediate family of any of the foregoing | 3,180 | $278K | 10b5-1 |
| 2026-09-02 | Azamian Bobak R. OFFICER | 10,000 | $801K | 10b5-1 |
| 2026-09-02 | Mottiwala Aziz Former Officer | 8,000 | $654K | |
| 2026-09-02 | Lin Elizabeth Yeu Officer | 5,387 | $431K | 10b5-1 |
| 2026-09-02 | Lin Elizabeth Yeu Member of immediate family of any of the foregoing | 1,590 | $127K | 10b5-1 |
| 2026-09-01 | Mottiwala Aziz Former Officer | 77,698 | $5.7M |
内部人 Insiders
LINK WILLIAM J PHD、Azamian Bobak R.、Lin Elizabeth Yeu、Neervannan Seshadri